{
  "ptid_time": "127_S_4210_2017-09-18",
  "img_path": "/data/qiuhui/data/adni/images/127_S_4210/2017-09-18/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 15,108 mm³, 49.7% below the reference mean. With a Z-score of -1.18 (11.9th percentile), this represents mild atrophy; hippocampal volume measures 8,868 mm³, 10.5% above the reference mean. With a Z-score of 1.05 (85.2th percentile), this represents mild enlargement; whole brain volume measures 1,176,710 mm³, 3.7% above the reference mean. With a Z-score of 0.53 (70.1th percentile), this represents normal volume ; entorhinal cortex volume measures 3,926 mm³, 7.9% below the reference mean. With a Z-score of -0.55 (29.2th percentile), this represents normal volume ; fusiform gyrus volume measures 22,084 mm³, 10.9% above the reference mean. With a Z-score of 0.91 (81.8th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,998 mm³, 10.8% below the reference mean. With a Z-score of -0.89 (18.8th percentile), this represents normal volume . ",
  "text_data": "Age is 69.9 years. Gender is Male. Education: 18 years. MMSE: 29.0. MoCA: 27.0. Logical Memory: 6.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.02 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain volume data shows mild ventricular enlargement (suggesting mild atrophy) but otherwise normal or even slightly enlarged volumes in key regions like the hippocampus and fusiform gyrus. Cognitive scores (MMSE 29, MoCA 27) are within normal limits, and amyloid PET (AV45) is normal. APOE4 heterozygous status increases Alzheimer’s risk but is not definitive.  \n\n**Diagnosis:** **CN (Cognitively Normal)**  \n**Confidence:** **High**  \n\n(No significant structural or biomarker evidence of neurodegeneration, and cognitive performance remains intact.)",
  "timestamp": "2025-07-26T13:16:43.045236"
}